results of retatrutide weight loss phase 2 trial Retatrutide: A Triple Agonist Shaping the Future Metabolic Care Retatrutide hits 28% weight loss

Older adults: standards of care in diabetes-2025

The patients who succeed through month 2 are the ones who throw everything at the problem, not the ones who try to minimize or endure without help

It can only be accessed through clinical trials or specific legal frameworks

This is a flexible, patient-centered approach

There are evidence that microglial cells also secrete GLP-1 in mice

I favor the deep plane technique for these patients because it lifts the face at the structural level rather than pulling on skin, which is exactly what a deflated face needs and its what produces results that look rested rather than done. Patients with earlier, milder changes may be candidates for a smaller procedure instead